Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathy. The aim of our study was to evaluate the diurnal relationship between arterial blood pressure and albuminuria, and some potential mechanisms responsible for impaired nocturnal blood pressure reduction (non-dippers, groups I and II) in diabetic nephropathy (DN). Twenty-four-hour ambulatory blood pressure, heart rate (HR) variation (autonomic nervous function) and extracellular fluid volume (ECV) were measured, and urine samples were collected three times during the corresponding day-and nighttimes in 47 insulin-dependent diabetic (IDDM) while neither the absolute nor the relative changes in MABP from day to night correlated significantly with absolute or relative changes in albuminuria from day to night. The night/day ratio of HR was higher in group I [0.93 (0.76-1.09), median (range)] compared to group III [0.83 (0.74-1.02), P < 0.005] and a significant correlation between this ratio and the night/day ratio of MABP was found (p = 0.54, P < 0.0005). ECV was about the same in the three groups. Our study indicated an association between blood pressure and albuminuria, but the mechanisms involved in the reduction of albuminuria from day to night was not unraveled. A relative lack of sympathetic withdrawal during sleep seems to be an important feature of nocturnal hypertension in diabetic nephropathy.
regulation, as demonstrated in IDDM patients with diabetic nephropathy [10] . Autonomic dysfunction has been suggested to play a role in the genesis of blunted nocturnal reduction in arterial blood pressure [11 and in urinary albumin excretion rate in IDDM patients without nephropathy [11] . The pathophysiological factors leading to blunted nocturnal arterial blood pressure reduction are likely to be multifactorial, as suggested by the recent finding that latent fluid retention may contribute to nocturnal hypertension in diabetic nephropathy [121. Our study aimed to elucidate a possible relationship between day to night changes in arterial blood pressure and day to night changes in the urinary albumin excretion rate, and to examine some potential mechanisms responsible for the impaired nocturnal arterial blood pressure reduction in IDDM patients with diabetic nephropathy.
Methods

Patients
Forty-seven consecutive IDDM patients with diabetic nephropathy, who fulfilled the following inclusion criteria were enrolled in the present study: persistent albuminuria > 300 mg/24 hr, glomerular filtration rate (GFR) 25 ml min1 . 1.73 m2, an average of three or more consecutive diastolic blood pressure readings 105 mm Hg, without antihypertensive treatment (except furosemide, N = 10), and age between 18 to 55 years. Patients were excluded if they had a previous history of stroke and/or transient ischemic attacks, congestive heart failure (NYHA III-IV), myocardial infarction or coronary bypass surgery within the last three months, and/or an unstable angina pectoris. All patients had been insulin-dependent from the time of diagnosis and all were receiving at least two daily injections of insulin. Diabetic nephropathy was diagnosed clinically if the following criteria were fulfilled: persistent albuminuria above 300 mg/24 hr, presence of diabetic retinopathy and no clinical or laboratory evidence of other kidney or renal tract disease, other than diabetic glomerulosclerosis [13] . Diabetic retinopathy was evaluated by fundus photography (Canon CFD-602, Kawasaki, Japan) after pupillary dilatation and graded as none, simplex or proliferative. Thirty-five patients had received antihypertensive treatment for at least two years; 26 patients were treated with an angiotensin converting enzyme inhibitor (ACE!) either alone (N = 7) or in combination with one or more conventional antihypertensive drugs (diuretics, calcium channel blockers, selective /3-blockers, a-blockers). Nine patients were treated with conventional antihypertensive drugs (see above). Three newly diagnosed hypertensive patients did not receive antihypertensive treatment. Nine patients were normotensive. Patients were divided according to the nocturnal reduction in arterial blood pressure in non-dippers (groups I and II) and dippers (group III). Non-dippers were defined as subjects with an average reduction in systolic and diastolic blood pressure from day to night of 10% [14] . The non-dippers were furthermore divided into two groups, group I below and group II above the median. All patients participating in the study were Caucasians, and all gave informed consent to participate in the study. The study was approved by the Regional Ethics Committee.
Methods
If treatment was given, all antihypertensive drugs were withdrawn four weeks before examination, except in ten patients receiving furosemide because of overt edemata. Three consecutive 24-hour urine samples were collected. They were all divided into day-and nighttime portions according to the actual bed times. The content of urinary albumin and sodium were measured by using an enzyme-linked immunoadsorbent assay [151 and a flame photometric method (Flame photometer FLM 3; Radiometer, Copenhagen, Denmark), respectively. Twenty-four-hour ambulatory blood pressure was measured simultaneously with the third 24-hour urine collection, at the homes of the patients, with a Takeda TM2420 device version 6 or 7 (A&D, Tokyo, Japan) [16] [17] [18] . A cuff size of 20 to 31 cm was used in patients with an arm circumference less than 32 cm and a cuff size of 28 to 36 cm was used in patients with an arm circumference above 32 cm.
Blood pressures and heart rates were measured every 15 minutes during the daytime (0700 to 2300 hours) and every 30 minutes during the nighttime (2300 to 0700 hours) [19] . Twenty-four-hour blood pressure measurements were accepted if at least 50% of the programmed pressures were measured successfully for each hour during the whole 24-hour monitoring interval. No editing was performed in the recorded blood presure values. Values were averaged for each hour before calculating day, night and 24-hour blood pressure. The mean arterial blood pressure was calculated as one-third of the difference betwr .n systolic and diastolic blood pressure plus the diastolic blood pressure.
The between visits coefficient of variation for ambulatory blood pressure (ABP) monitoring for systolic blood pressure was: 24-hour 6%, daytime 6%, nighttime 7%; for diastolic blood pressure the ABP was: 24-hour 8%, daytime 11%, and nighttime 10%.
Cardiac autonomic nervous function (primarily parasympathetic) was assessed by the beat-to-beat variation during deep breathing [< 4 beats min (abolished), 5 to 15 beats min1 (impaired) and > 15 beats min1 (normal)] [20, 21] . The coefficient of variation for beat-to-beat variation during deep breathing is 24% in our laboratory. As an overall indicator, mainly of cardiac and neurohumeral sympathetic activity, we determined the night/day ratio of heart rate [22, 23] . Determination of the GFR and extracellular fluid volume (ECV) were performed with the patients in the supine position between 8 a.m and 1 p.m., after an overnight fast. Patients had breakfast and morning insulin 30 minutes after the start of the investigation, and drank approximately 200 ml of tap water per hour during the investigation period. GFR was measured after a single intravenous injection of 3.7 MBq 5Cr-labeled eidetic acid (51Cr-EDTA) at 8 a.m., by determining the radioactivity in venous blood samples 180, 200, 220 and 240 minutes after the injection [24, 25] . Extracellular fluid volume was determined to be the distribution volume of 51Cr-EDTA [26] . The results were standardized for 1.73 m2 body surface area. The mean intra-individual coefficient of variation of the glomerular filtration rate and extracellular fluid volume from day to day is 4% and 15%, respectively, in our laboratory. Body mass index (BMI) was calculated as weight (kg) height (m)2. From venous blood samples hemoglobin A1 (HbA1) was measured by high-performance liquid chromatography (DIAMAT analyzer; Bio-Rad, CA, USA). The normal range of HbA1C in our laboratory is 4.1 to 6.4%.
Statistical analysis
All data are expressed as median (range), except when indicated. The Mann-Whitney U-test and the Kruskal-Wallis test of variance was used to test for differences between two and three groups, respectively. The Wilcoxon signed-ranks test was used to test paired data. For each patient the night and day urinary albumin excretion rates and the urinary sodium excretion rate are expressed as the median of three night and day collections, respectively. Correspondingly, the night/day ratios of the urinary albumin excretion rate and urinary sodium excretion rate for each patient are represented as the median of three night/day ratios. The chi-square test was used for evaluating frequencies. Spearman's rank correlation coefficient was used for correlations, except when indicated. All calculations were made using Statgraphics (STSC; Rockville, MD, USA). A P value of < 0.05 was considered significant (two-tailed).
Results
The three groups with different nocturnal arterial blood pressure reduction were similar with respect to the following: sex ratio, age, duration of diabetes, HbAIC, BMI, insulin dosage, duration of diabetic nephropathy and level of retinopathy (Table 1) . Furthermore, the nine normotensive patients were equally distributed among the three groups.
There was a significant decline in MABP from 107 (86-137) mm Hg during daytime to 100 (76-144) mm Hg during nighttime (P < 0.0001) in the whole group of patients. A similar diurnal pattern was observed in albuminuria: 1123 (170-6719) jsg min1 (daytime) versus 841 (81-4665) jsg min1 (nighttime) (P < 0.0001). The median glomerular filtration rate was 82 (32-139) ml min1 1.73 m2 and the median extracellular fluid volume was 14 .0 (11.0 -18.5) liters• 1.73 m2. Table 2 illustrates the results in the three groups of patients. Daytime MABP and 24-hour MABP values were alike in the three groups. The daytime heart rate (HR) was comparable in the three groups, while the nighttime HR tended to be highest in group I and lowest in group III, with group II in-between (P = 0.09). The night/day ratio of HR was higher in group I compared to group III (P < 0.005). Furthermore, we found a correlation between the night/day ratio of HR and the night/day ratio of arterial blood pressure (p = 0.54, P < 0.0005; Fig. 1 ). Group I, completely lacking nocturnal blood pressure reduction, tended to have the highest albumin excretion rate both during night-and daytimes (P < 0.15, comparing group I vs. group III). No significant differences were found in the ratio of night to day urinary excretion rates of albuminuria and sodium between the three groups. Glomerular filtration rate, extracellular Patients are divided according to the nocturnal reduction in arterial blood pressure in non-dippers (group I and II) and dippers (group III).
Non-dippers are defined as subjects with an average reduction in systolic and diastolic blood pressure from day to night of 10%. The non-dippers are furthermore divided into two groups, group I below and group II above the median. Patients are divided according to the nocturnal reduction in arterial blood pressure in non-dippers (group I and II) and dippers (group III).
Non-dippers are defined as subjects with an average reduction in systolic and diastolic blood pressure from day to night of 10%. The non-dippers are furthermore divided into two groups, group I below and group II above the median.
a Between group I-Il h Between group Il-Ill Between group I-Ill fluid volume and beat-to-beat variation during deep breathing were about the same in all three groups. Significant correlations between daytime MABP and daytime albuminuria (p = 0.52, P < 0.0005; Fig. 2 ), between nighttime MABP and nighttime albuminuria (p = 0.46, P < 0.005; Fig. 2) , and between 24-hour MABP and 24-hour albuminuria (p 0.57, P < 0.0005) were found. No significant correlations between the night/day ratio of MABP and night/day ratio of albuminuria (p = 0.02, P = 0.89; Fig. 3 ), between nighttime MABP minus daytime MABP and nighttime albuminuria minus daytime albuminuria (p = -0.14, P = 0.35), or between log (nighttime albuminuria)/log (daytime albuminuria) and night/day ratio of MABP (r = 0.08, P = 0.59, linear regression) were found.
The 47 patients were divided into two groups according to the median value of ECV (14.0 liter 1.73 m2). One group of patients had an ECV below the median and another group of patients an ECV above the median. Clinical and laboratory characteristics of the two groups were comparable, except the extracellular fluid volume (Table 3 ). In both groups there was a significant reduction in systolic and diastolic blood pressure from day to night of 5%/5% in patients with an ECV below the median and 8%/9% in patients with an ECV above, respectively. The night/day ratio of systolic and diastolic blood pressure was not significantly different between the two groups ( Table 3 ). The degree of nocturnal reduction in arterial blood pressure was normally distributed in both groups. The difference in nocturnal arterial blood pressure reduction between patients with an ECV below and above the median, was -3.4% with a 95% confidence interval from -8.5 to 1.7%. The urinary sodium excretion rate tended to be lower in patients with an ECV below the median compared with patients with an ECV above (P < 0.06) during daytime, but was the same during nighttime (Table 3) . Omitting the ten patients treated with furosemide had no significant impact on the variables presented in Table 3 .
Discussion
Our cross-sectional study in IDDM patients with diabetic nephropathy revealed an impaired nocturnal arterial blood pressure reduction in the majority of the patients, a relationship between arterial blood pressure and albuminuria during the day and night measurements, and a lack of association between the absolute or relative degree of nocturnal arterial blood pressure reduction and the absolute or relative degree of nocturnal reduction in albuminuria. Our study suggests that impaired cardiac autonomic nervous function (mainly lack of sympathetic withdrawal) during sleep is an important feature of nocturnal hypertension in IDDM patients with diabetic nephropathy and wellpreserved kidney function. Extracellular fluid retention was not related significantly to the presence or absence of arterial blood pressure dipping.
The diurnal rhythmicity of albuminuria depends on alterations in the filtered load and/or tubular reabsorption of albumin. A major increase in tubular protein reabsorption from day to night is highly unlikely, since the protein reabsorption capacity is fully saturated in protenuric patients. Furthermore, the observed changes in the urinary /32-microglobulin excretion rate in nephropathic patients cannot account for the circadian rhythm of proteinuria [27] . The filtered load of albumin depends on serum albumin concentration, the size and charge selective properties of Night/day ratio of heart rate E Fig. 1 . Correlation between the variation in night to day heart rate and variation in night to day mean arterial blood pressure (MABP) (rho = 0.54, up < 0.01 compared to nighttime blood pressure b NS compared to nighttime urinary sodium excretion rate (UNaE) C At time of investigation Only patients receiving furosemide the glomerular capillary barrier, and the transglomerular hydraulic pressure difference. Before discussing the different determinants it should be recalled that diurnal changes in albuminuria is present during 24-hour recumbency and during spaced identical meals (protein intake) [2, [28] [29] [30] . Diurnal alterations in serum albumin concentration cannot explain the reduction in albuminuria from day to night in non-diabetic nephropathies [2] . Changes in the size and charge selective properties of the glomerular capillary wall is well documented in IDDM patients with diabetic nephropathy [31] [32] [33] [34] . However, we have no information on diurnal variations in these properties of the glomerular capillary wall in diabetic glomerulopathy, while some patients with non-diabetic glomerulopathies have a diurnal variation in the selectivity index (fractional clearance of IgG/transferrin) [2, 3] , the ratio being lowest during nighttime. A redistribution of blood flow to nephrons with different protein permeability as suggested by Arisz [35] may contribute to the circadian rhythmicity in albuminuria, if present in diabetic nephropathy. Increased glomerular capillary hydraulic pressure (PGC) enhances the transglomerular albumin passage in diabetic and non-diabetic animals with various experimental glomerulopathies [36] . Conversely, acute and chronic reduction in P0 lowers urinary albumin excretion [37] . We have previously demonstrated that acute reduction in arterial blood pressure reduces albuminuria and GFR in IDDM patients suffering from diabetic nephropathy [101. Recently we found a relationship between chronic changes in MABP and changes in both albuminuria and GFR in diabetic nephropathy [38] . The previous demonstration of impaired or in some cases even completely abolished autoregulation of GFR (and probably also PGC) may aggravate the impact of reduction in MABP on glomerular hemodynamics. Even though our study revealed a correlation between MABP and albuminuria both during day-and nighttime, as reported recently by Mulec et a! [12] , no relationship was demonstrated between the variation from day to night in MABP and albuminuria. Patients with a blunted nocturnal decline in MABP (non-dippers) had the same degree of day to night reduction in albuminuria as did the dippers.
This finding suggests that either the arterial blood pressure reduction was not transmitted to the glomerular capillaries, because of changes in the ratio of the afferent/efferent arteriolar resistance, or that other non-hemodynamic determinants of albuminuria offset the reducing effect of blood pressure lowering. It should be mentioned that the circadian rhythm of GFR is not determined by the circadian variation of MABP in diabetic patients (B.A.C. van Acker, personal communication). However, the diurnal variation in GFR will tend to reduce the circadian variation in fractional albumin clearance (albuminuria GFR' serum albumin concentration').
Twenty-four-hour blood pressure and heart rate measurements have shown a circadian variation, characterized by a decline in both variables during nighttime compared to daytime [39, 40] . During non-rapid eye movement sleep, this decline in blood pressure is due to reduced cardiac output and is caused by a reduction in heart rate and normal/reduced stroke volume, and a decrease in peripheral resistance [41] , owing to a reduction in sympathetic tone . The diminishing in heart rate is due to a withdrawal of sympathetic activity and an increase in parasympathetic tone [21, 40] . A blunted decline in arterial blood pressure during night has been observed in IDDM and NIDDM patients with diabetic nephropathy [1, 7, 8] . The pathophysiological factors responsible for this abnormal day to night variation in arterial blood pressure in diabetic nephropathy is likely to be multifactorial; latent fluid retention [121 and cardiac and neurohumoral autonomic dysfunction may play roles in this mechanism. Our finding of a positive correlation between the night/day ratio of heart rate and the night/day ratio of arterial blood pressure suggest that there is a relative lack of sympathetic withdrawal during sleep, which might be an important feature of nocturnal hypertension in diabetic nephropathy. This suggestion is based on recent 24-hour ECG findings showing that diminished day/night difference in mean RR interval, that is, heart rate, in subjects with and without diabetic nephropathy is mainly caused by lack of withdrawal of sympathetic activity during night [22, 23] . We found no significant correlation between the beat-to-beat variation during deep breathing (reflects mainly cardiac vagus activity) and the degree of arterial blood pressure dipping.
Diabetic nephropathy is nearly always accompanied by a varying degree of extracellular fluid retention, which seems to play a dominant role in the initiation and maintenance of arterial blood pressure elevation in diabetic nephropathy [45] . Recently, Mulec et at [12] demonstrated that there was no nocturnal decline in arterial blood pressure in IDDM patients with diabetic nephropathy, and an ECV above the median as compared with patients with an ECV below the median. All patients were treated with diuretics, one patient with hydrochlorothiazide, the others with furosemide. Furthermore, nearly 50% received an additional beta-blockade treatment. Their mean GFR was 39 ml min1
1.73 m2. The blunted nocturnal decline in arterial blood pressure in patients with diabetic nephropathy could be due to a re-entry of edema fluid into the circulation during recumbency at night, causing an increase in intravascular volume [121. This would lead to improved cardiac filling and cardiac output. Our data in IDDM patients with diabetic nephropathy with well-preserved GFR [mean (SD) 85 (27) ml min 1.73 m2] do not support the concept that latent overhydration leads to nocturnal hypertension. We found no significant difference in the nocturnal reduction in arterial blood pressure in patients with an ECV below the median, compared to patients with an ECV above the median. The risk of overlooking a difference in nocturnal arterial blood pressure reduction of more than + 1.7% between patients with an ECV below and patients with an ECV above the median, is less than 5%.
Extracellular fluid volume was calculated according to the method described by BrOchner-Mortensen [26] , both in the study of Mulec et al [12] and in the present study. The ECV [mean (SD), 14.2 (1.7) liter-1.73 m2] in our study is similar to the ECV (14.5 liter 1.73 m2) previously reported in IDDM patients with diabetic nephropathy and well-preserved kidney function (107 ml • min' 1.73 rn-2) [45] . The normal values for ECV presented as percent of body wt is 19.5% in men and 18.8% in women [46] . The difference in ECV between patients above and below the median value of ECV were comparable in the study of Mulec et at [12] and in our study [ECV, mean (5EM), was 12.9 (0.2) liter -1.73 m2 in group A and 15.4 (0.3) liter -1.73 m2 in group B], 2.2 liter versus 2.5 liter, respectively. Differences in the degree of impaired kidney function and drug therapy are suggested as the most likely explanations for the discrepancy between the past [12] and the present studies. Enhanced nighttime sodium excretion rate has been demonstrated in hypertensive patients with loss of nocturnal decline in arterial blood pressure [47] and in some diabetic patients with autonomic neuropathy [11] . Our study showed a tendency for a reverse night/day urinary excretion rate of sodium.
In conclusion, our study indicates an association between arterial blood pressure and albuminuria, but the mechanisms involved in the reduction of albuminuria from day to night are attributed largely to mechanisms other than blood pressure changes. A relative lack of sympathetic withdrawal during sleep seems to be an important feature of nocturnal hypertension in diabetic nephropathy.
